SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-07-25 |
| Reported value | $371,704,828 |
| Positions | 39 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| ELI LILLY & CO | LLY | COM | $35,768,202 | 29,821 |
| MERCK & CO. INC | MRK | COM | $24,332,374 | 189,357 |
| JOHNSON & JOHNSON | JNJ | COM | $21,695,387 | 85,425 |
| ABBVIE INC | ABBV | COM | $16,186,743 | 64,325 |
| CVS HEALTH CORP | CVS | COM | $15,114,251 | 146,102 |
| THERMO FISHER SCIENTIFIC CORP | TMO | COM | $13,967,388 | 27,859 |
| REVOLUTION MEDICINES INC | RVMD | COM | $13,685,860 | 73,077 |
| BIOGEN INC | BIIB | COM | $13,564,462 | 62,781 |
| NEUROCRINE BIOSCIENCES INC | NBIX | COM | $12,285,864 | 72,898 |
| MIRUM PHARMACEUTICALS INC | MIRM | COM | $11,801,475 | 100,807 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.